Analysts Are Bullish on These Healthcare Stocks: Cormedix (CRMD), TG Therapeutics (TGTX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cormedix (CRMD – Research Report) and TG Therapeutics (TGTX – Research Report) with bullish sentiments.

Cormedix (CRMD)

Needham analyst Serge Belanger maintained a Buy rating on Cormedix today and set a price target of $13.00. The company’s shares closed last Thursday at $3.09, close to its 52-week low of $2.65.

According to TipRanks.com, Belanger has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -5.2% and a 37.5% success rate. Belanger covers the Healthcare sector, focusing on stocks such as Clarus Therapeutics Holdings, Amphastar Pharmaceuticals, and Phasebio Pharmaceuticals.

Cormedix has an analyst consensus of Strong Buy, with a price target consensus of $14.33, implying a 371.4% upside from current levels. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $14.00 price target.

See today’s best-performing stocks on TipRanks >>

TG Therapeutics (TGTX)

B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on TG Therapeutics today and set a price target of $17.00. The company’s shares closed last Thursday at $8.57, close to its 52-week low of $3.48.

According to TipRanks.com, Mamtani is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -31.6% and a 20.1% success rate. Mamtani covers the Healthcare sector, focusing on stocks such as Lineage Cell Therapeutics, Arrowhead Pharmaceuticals, and Spectrum Pharmaceuticals.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for TG Therapeutics with a $18.00 average price target, which is a 208.7% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $19.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CRMD:

• Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Ayr Wellness (AYRWF)
• Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination
• Analysts Conflicted on These Healthcare Names: Biogen (BIIB), Apyx Medical (APYX) and Phathom Pharmaceuticals (PHAT)
• Here’s Why Sunrun and Other Solar Stocks are Rallying
• Maxim Group Reaffirms Their Hold Rating on Kiora Pharmaceuticals (KPRX)